Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash & Equivalents: 2013-2017

Historic Cash & Equivalents for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2017 value amounting to $5.1 million.

  • Armata Pharmaceuticals' Cash & Equivalents rose 73.37% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.4 million, marking a year-over-year increase of 73.37%. This contributed to the annual value of $5.1 million for FY2017, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Cash & Equivalents of $5.1 million as of FY2017, which was down 0.00% from $5.1 million recorded in FY2016.
  • In the past 5 years, Armata Pharmaceuticals' Cash & Equivalents ranged from a high of $20.4 million in FY2013 and a low of $5.1 million during FY2016.
  • Its 3-year average for Cash & Equivalents is $6.5 million, with a median of $5.1 million in 2017.
  • In the last 5 years, Armata Pharmaceuticals' Cash & Equivalents crashed by 67.67% in 2014 and then spiked by 42.38% in 2015.
  • Over the past 5 years, Armata Pharmaceuticals' Cash & Equivalents (Yearly) stood at $20.4 million in 2013, then plummeted by 67.67% to $6.6 million in 2014, then soared by 42.38% to $9.4 million in 2015, then crashed by 45.23% to $5.1 million in 2016, then remained steady at $5.1 million in 2017.